Skip to main content
Log in

Potentin Vitro anticancer activity of metacycloprodigiosin and undecylprodigiosin from a sponge-derived actinomyceteSac-charopolyspora sp. nov.

  • Articles
  • Drug Design
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

Bioassay-guided fractionation of CHCI3 extract from the fermentation broth of a spongeMycale plumose-derived actinomyceteSaccharopolyspora sp. nov., led to the isolation of two known prodigiosin analogs - metacycloprodigiosin (1) and undecylprodigiosin (2). These compounds exhibited significant cytotoxic activities against five cancer cell lines: P388, HL60, A-549, BEL-7402, and SPCA4. This is the first report on the significant cytotoxicity of metacycloprodigiosin (1 ) against human cancer cell lines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Ricardo, P. A., Beatriz, M., Esther, L, and Vanessa, S. C, The prodigiosins, proapoptotic drugs with anticancer properties.Biochem. Pharmacol., 66,1447–1452 (2003).

    Article  Google Scholar 

  • Furstner, A., Grabowski, J., Lehmann, W., Kataoka, T. T., and Nagai, K., Synthesis and biological evaluation of nonylpro-digiosin and macrocyclic prodigiosin analogues.Chem. Bio. Chem., 2, 60–68 (2001).

    PubMed  CAS  Google Scholar 

  • Nakamura, ?., Nagai, K., Ando, K., and Tamura, G, Selective suppression by prodigiosin of the mitogenic response of murine splenocytes.J. Antibiot., 39, 1155–1159 (1986).

    PubMed  CAS  Google Scholar 

  • Spongia, S., Mortellaro, ?., Taverna, S., Fomasiero, C., Sheiber, E. A, Erba, E., Colotta, F., Mantovani, A., Isetta, A. M., and Golay, J., Characterization of the new immunosuppressive drug undecylprodigiosin in human lymphocytes: retinoblastoma protein, cyclin-dependent kinase-2, and cyclin-dependent kinase-4 as molecular targets.J. Immunol., 158, 3987–3995 (1997).

    Google Scholar 

  • Matsuya, H., Okamoto, M., Ochi, T, Nishikawa, A., Shimizu, S., Kataoka, T, Nagai, K., Wasserman, H. H., and Ohkuma, S., Reversible and potent uncoupling of hog gastric (H+ + K+)-ATPase by prodigiosins.Biochem. Pharmacol., 60, 1855–1863 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Sato, T, Konno, H., Tanaka, Y, Kataoka, T., Nagai, K., Wasserman, H. H., and Ohkuma, S., Prodigiosins as a new group of H+/Cl- symporters that uncouple proton translocators.J. Biol. Chem., 273, 21455–21462 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Skehan, P., Storeng, R., Scudiero, D., Monks, ?., McMahon, J., Vistica, D., Warren, J. T, Bokesch, H., Kenney, S., and Boyd, M. R., New colorimetric cytotoxicity assay for anticancer drug screening.J. Natl. Cancer Inst, 82,1107–1112 (1990).

    Article  PubMed  CAS  Google Scholar 

  • Wasserman, H. H., Rodgers, G. C, and Keith, D. D., Metacyclo-prodigiosin, atripyrrole pigment fromStreptomyces longisporus ruber.J. Am. Chem. Soc, 91,1263–1264 (1969a).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Qian-Qun Gu or Wei-Ming Zhu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, R., Cui, CB., Duan, L. et al. Potentin Vitro anticancer activity of metacycloprodigiosin and undecylprodigiosin from a sponge-derived actinomyceteSac-charopolyspora sp. nov.. Arch Pharm Res 28, 1341–1344 (2005). https://doi.org/10.1007/BF02977899

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02977899

Key words

Navigation